OptiBiotix Health plc (LON:OPTI) is to show off a range of new SlimBiome products and the latest research data on its LPLDL heart health products at a prestigious industry conference in Switzerland next week.
The life sciences group has been developing a range of new product concepts which feature its SlimBiome weight loss ingredient, including natural fruit gummies, muesli pots, Nutri-Bites and flavours for new bars; all of which it will showcase at Vitafoods European trade show in Geneva next week.
READ: OptiBiotix jumps on news of potential commercial partner
SlimBiome and LPLDL nominated for awards
Opti will also present results from its human studies on SlimBiome which showed that people who took the ingredient felt fuller, had less cravings and were more likely or make positive changes to their food choices.
Alongside its manufacturing partner, Sacco, the AIM-listed company will also showcase its LPLDL cholesterol and blood pressure-reducing probiotic in a number of new product concepts, while Opti will also present fresh results of its human studies.
OptiBiotix is also up for a couple of awards at the conference: SlimBiome has been shortlisted for the 'Ingredient of the Year: Weight Management' award, while LPLDL has been shortlisted as 'Probiotic Product of the Year'.
New opportunities
“We are extremely pleased to be attending Vitafoods with a range of new products, new human studies on SlimBiome and a growing list of industry partners,” said chief executive Stephen O’Hara.
“We are confident that our participation at VitaFoods will help progress existing discussions with corporate partners and open up opportunities in new territories for the manufacture and distribution of our growing range of products.”
He added: “Finally, we are really excited by the results of the human study on SlimBiome.”